Mwandishi
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
Jumanne, 14 Julai 2026, 12:55:47 UTC
Pseudomembranous colitis management
Pseudomembranous colitis management
Pseudomembranous colitis is caused by Clostridium difficile, a Gram-positive anaerobic bacterium that causes antibiotic-associated diarrhea due to alteration of normal intestinal flora and release of enterotoxins.
Clinical presentation
Bloody diarrhea
Abdominal cramps and tenderness
Nausea
Fever
Dehydration
Investigations
Lower endoscopy showing characteristic pseudomembranous yellowish plaques overlying ulcerated and friable rectosigmoid colonic mucosa
Laboratory evidence of C. difficile toxin A/B:
Stool toxin assay (Toxin B)
ELISA assay (Toxin A)
Pharmacological treatment
Discontinue causative antibiotic
Stop the suspected precipitating antibiotic whenever possible.
Antimicrobial therapy
Metronidazole
Metronidazole (PO) 400 mg 8 hourly for 10–14 days
OR
Vancomycin
Vancomycin (PO) Adults: 125–500 mg 6 hourly for 10–14 days
Supportive management
Fluid and electrolyte replacement as indicated
Monitor hydration status and clinical response
Note Resuscitative and supportive management should be instituted as described for ulcerative colitis. Refer to the next level of care with adequate expertise and facilities for all suspected cases requiring initial evaluation and management. Urgent referral is required for patients presenting with acute complications such as toxic megacolon.
Imeandikwa:
Jumatatu, 22 Juni 2026, 12:14:35 UTC
References:
